Cargando…

Salvage Brachytherapy for Castration-Resistant and External Beam Radiotherapy-Resistant Local Recurrence 17 Years after Radical Prostatectomy

A 47-year-old Japanese man was diagnosed with prostate cancer in February 1995 (Initial PSA 77.2 ng/mL, GS3 + 4, cT3N0M0). He underwent radical prostatectomy after androgen deprivation therapy (ADT) in June 1995. Nine years after operation, he was diagnosed with local recurrence of prostate cancer a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosogoe, Shogo, Soma, Osamu, Matsumoto, Teppei, Imai, Atsushi, Hatakeyama, Shingo, Yoneyama, Takahiro, Hashimoto, Yasuhiro, Koie, Takuya, Ohyama, Chikara, Aoki, Masahiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4480240/ https://www.ncbi.nlm.nih.gov/pubmed/26171272 http://dx.doi.org/10.1155/2015/839738

Ejemplares similares

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study
por: Iwamura, Hiromichi, et al.
Publicado: (2015)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer
por: Osamu, Soma, et al.
Publicado: (2017)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

Frailty is a predictor of moderate to severe pain after robot‐assisted laparoscopic prostatectomy: A case‐control study (FRAP study)
por: Momota, Masaki, et al.
Publicado: (2020)

Renal cell carcinoma in a lumbar ectopic kidney
por: Hamano, Itsuto, et al.
Publicado: (2019)

Aortic calcification burden predicts deterioration of renal function after radical nephrectomy
por: Fukushi, Ken, et al.
Publicado: (2017)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

Efficacy of SMART Stent Placement for Salvage Angioplasty in Hemodialysis Patients with Recurrent Vascular Access Stenosis
por: Hatakeyama, Shingo, et al.
Publicado: (2011)

A Case of Primary Renal Carcinoid Tumor
por: Tanaka, Toshikazu, et al.
Publicado: (2015)

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study
por: Hagiwara, Kazuhisa, et al.
Publicado: (2016)

Presurgical therapy with axitinib for advanced renal cell carcinoma: a case report
por: Koie, Takuya, et al.
Publicado: (2013)

Robotic cross‐folded U‐configuration intracorporeal ileal neobladder for muscle‐invasive bladder cancer: Initial experience and functional outcomes
por: Koie, Takuya, et al.
Publicado: (2018)

Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma
por: Hosogoe, Shogo, et al.
Publicado: (2017)

Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer
por: Kubota, Yuka, et al.
Publicado: (2019)

Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study
por: Hamaya, Tomoko, et al.
Publicado: (2021)

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
por: Koie, Takuya, et al.
Publicado: (2015)

Gene Expression Changes in Venous Segment of Overflow Arteriovenous Fistula
por: Hashimoto, Yasuhiro, et al.
Publicado: (2013)

A Case of Fibrous Pseudotumor in the Scrotum: Challenge for Diagnosis and Testicular Preservation
por: Kodama, Hirotake, et al.
Publicado: (2018)

Proton pump inhibitor as an independent factor of progression of abdominal aortic calcification in patients on maintenance hemodialysis
por: Okamoto, Teppei, et al.
Publicado: (2018)

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity
por: OKAMOTO, TEPPEI, et al.
Publicado: (2013)

Clinical relevance of aortic calcification in urolithiasis patients
por: Tanaka, Toshikazu, et al.
Publicado: (2017)

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis
por: Tanaka, Yoshimi, et al.
Publicado: (2017)

Risk-stratified surveillance and cost effectiveness of follow-up after radical cystectomy in patients with muscle-invasive bladder cancer
por: Kusaka, Ayumu, et al.
Publicado: (2017)

Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer
por: Hamano, Itsuto, et al.
Publicado: (2017)

Salvage focal brachytherapy in castration‐resistant prostate cancer with neuroendocrine differentiation after radiation therapy
por: Komori, Takahiro, et al.
Publicado: (2022)

Chromophobe renal cell carcinoma with concomitant sarcomatoid transformation and osseous metaplasia: a case report
por: Tanaka, Yoshimi, et al.
Publicado: (2013)

Surgical Treatment of a Giant Liposarcoma in a Japanese Man
por: Hashimoto, Yasuhiro, et al.
Publicado: (2010)

I‐branching N‐acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling
por: Mikami, Jotaro, et al.
Publicado: (2016)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Nonmetastatic castration‐resistant prostate cancer treated with salvage focal brachytherapy after external beam radiotherapy
por: Yoshida, Soichiro, et al.
Publicado: (2021)

Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient
por: Narita, Takuya, et al.
Publicado: (2014)

Comparison of neoadjuvant chemohormonal therapy vs. extended pelvic lymph-node dissection in high-risk prostate cancer treated with robot-assisted radical prostatectomy
por: Oishi, Takuya, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_elet29c06i7cvnsscnh0kfuhsb